Clinical Trials for Prinicipal Investigator: Nataliya Mar

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-17-18 A Single-Arm, Open-Label, Multicenter Study of Enfortumab Vedotin (ASG-22CE) for Treatment of Patients with Locally Advanced or Metastatic Urothelial Cancer who Previously Received Immune Checkpoint Inhibitor (CPI) Therapy Open